BALTIMORE – Genomic sequencing has been adopted rapidly for clinical use in recent years, but its regulation is still taking shape in the US and in Europe, according to a discussion on the barriers and drivers for the implementation of clinical sequencing here at the American Society of Human Genetics annual meeting on Wednesday.